ANFARM’s international activities range from licensing to exports and 3rd party services for numerous countries in Europe, Canada and Asia as well as in the emerging generic markets of MENA, LATAM and Oceania.
ANFARM’s state of the art manufacturing facilities coupled with an exceptional team of R&D scientists provide the assurance of a smooth transition from lab to commercial scale, as well as in-depth scientific know-how for tech transfers, product development and development and/or optimization of lyophilization cycles.
Our main activities include:
• Licensing out & International Sales
• Regulatory Affairs Services
• New Product Development
• Contract Development
• Tech Transfer & Contract Manufacturing
• Development / Optimization of Lyophilization Cycles
Company Details
- Employees
- 143
- Founded
- -
- Address
- 4 Achaias, Kifisiá,attiki 145 64,greece
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- anfarm.com
- Keywords
- EU GMP Certified Pharmaceuticals' Manufacturer, 3rd Party Manufacturer, Licensing Out, Product Development Services, New Product R&D, Technology Transfer, Exports, CDMO, lyophilization cycles, Contract Development, RA Services, Tech Transfer.
- HQ
- Kifisiá, Attiki
Anfarm Questions
Anfarm's website is anfarm.com
Anfarm's LinkedIn profile is https://gr.linkedin.com/company/anfarm-hellas-sa
Anfarm has
143 employees.
View email and phone details for 143
employees at Anfarm.
Anfarm's industry is
Pharmaceutical Manufacturing
Anfarm's top competitors are
Uni-Pharma Pharmaceutical Laboratories S.a.,
Elpen Pharmaceutical Co. Inc.,
Rafarm S.a.,
Bennett Pharmaceutical Industry,
Famar,
Lavipharm,
Vianex Sa,
Pharmathen,
Genepharm Sa,
Demo Pharmaceuticals S.a..
Anfarm's categories are Pharmaceutical Manufacturing
Anfarm's founding year is 1967
